A versatile drug delivery system targeting senescent cells
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Senescent cells accumulate in multiple aging‐associated diseases, and eliminating these cells has recently emerged as a promising therapeutic approach. Here, we take advantage of the high lysosomal β‐galactosidase activity of senescent cells to design a drug delivery system based on the encapsulation of drugs with galacto‐oligosaccharides. We show that gal‐encapsulated fluorophores are preferentially released within senescent cells in mice. In a model of chemotherapy‐induced senescence, gal‐encapsulated cytotoxic drugs target senescent tumor cells and improve tumor xenograft regression in combination with palbociclib. Moreover, in a model of pulmonary fibrosis in mice, gal‐encapsulated cytotoxics target senescent cells, reducing collagen deposition and restoring pulmonary function. Finally, gal‐encapsulation reduces the toxic side effects of the cytotoxic drugs. Drug delivery into senescent cells opens new diagnostic and therapeutic applications for senescence‐associated disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“One approach stems from the increase in lysosomal mass and senescence-associated β-galactosidase activity in many senescent cells, whereby galacto-oligosaccharide-coated nanoparticles and β-galactosidase-activated prodrugs appear to eliminate at least some of these cells92,93.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [92]
The cited source says what the claim attributes to it.
In the citing paper
“Nanoparticles containing either fluorophores or cytotoxic agents coated with galacto-oligosaccharides were found to preferentially deliver cytotoxic cargo to senescent cells because of the higher level of SA-β-gal activity in these cells218.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [218]
The cited source says what the claim attributes to it.
In the citing paper
“A senescence transcriptional signature could enable rapid detection of senescent cells, and multiple such gene sets have been described132–136,139.”
From Guidelines for minimal information on cellular senescence experimentation in vivo (2024) · cites this paper as [134]
The cited source says what the claim attributes to it.
In the citing paper
“Galacto-oligosaccharide encapsulated nanoparticles (GalNP) containing cytotoxic or senolytic drugs (Muñoz-Espín et al. 2018) and galactose-derived prodrugs display senolytic properties (González-Gualda et al. 2020; Guerrero et al. 2020)”
From Senescence and the SASP: many therapeutic avenues (2020) · cites this paper as Muñoz-Espín et al. 2018
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Spatial omics has not yet been used extensively for senescence research but is in development132–136.”
From Guidelines for minimal information on cellular senescence experimentation in vivo (2024) · cites this paper as [134]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106 · cited 1×
“0.10 (Trapnell et al, 2012), Bowtie 1.0.0 (Langmead et al, 2009) and Samtools 0.1.19.0 (Li et al, 2009); and transcripts assembly, abundances estimation, and differential expression were calculated with DESeq2 (Love et al, 2014).”
InfluentialThe Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041 · cited 1×
“0.10 (Trapnell et al, 2012), Bowtie 1.0.0 (Langmead et al, 2009) and Samtools 0.1.19.0 (Li et al, 2009); and transcripts assembly, abundances estimation, and differential expression were calculated with DESeq2 (Love et al, 2014).”
MethodInfluentialUltrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849 · cited 1×
“0.10 (Trapnell et al, 2012), Bowtie 1.0.0 (Langmead et al, 2009) and Samtools 0.1.19.0 (Li et al, 2009); and transcripts assembly, abundances estimation, and differential expression were calculated with DESeq2 (Love et al, 2014).”
MethodInfluentialOrdered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism
Kresge, C. T., Leonowicz, M. E., Roth, W. J., Vartuli, J. C., & Beck, J. S. (1992) · Nature · doi:10.1038/359710a0 · Cited by 16,275 · cited 4×
“For the synthesis of the mesoporous silica MCM-41 scaffolds (Kresge et al, 1992), N-cetyltrimethylammonium bromide (CTAB, Sigma, #H6269) was first dissolved in 480 ml of deionized water at 2.74 mM.”
BackgroundMethodInfluentialTrapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 12,116 · cited 1×
“0.10 (Trapnell et al, 2012), Bowtie 1.0.0 (Langmead et al, 2009) and Samtools 0.1.19.0 (Li et al, 2009); and transcripts assembly, abundances estimation, and differential expression were calculated with DESeq2 (Love et al, 2014).”
MethodInfluentialA biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218 · cited 1×
“In this regard, it is relevant to mention that macrophages are known to metabolize nanoparticles (Wilhelm et al, 2016) and can present SAbGal activity without actually being senescent (Hall et al, 2017).”
BackgroundNaturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876 · cited 1×
“Published under the terms of the CC BY 4.0 license EMBO Molecular Medicine 10: e9355 | 2018 1 of 18 processes associated with chemotherapy, and extends longevity (Baker et al, 2016; Childs et al, 2016; Demaria et al, 2017).”
MethodInfluentialCellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Self-citationThe Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584 · cited 3×
“Importantly, senescent cells present vulnerabilities to particular small molecule inhibitors, known as “senolytics”, that trigger apoptosis preferentially in senescent cells (Zhu et al, 2015).”
Background
Cited by
Items 201–300 of 339
Lozano‐Torres, B., García‐Fernández, A., Domínguez, M., Sancenón, F., Blandez, J. F., & Martínez‐Máñez, R. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c04766 · Cited by 22
Self-citationPogacar, Z., Johnson, J. L., Krenning, L., De Conti, G., Jochems, F., Lieftink, C., Velds, A., Wardak, L., Groot, K., Schepers, A., et al. (2022) · PLOS ONE · doi:10.1371/journal.pone.0273182 · Cited by 13
Cellular uptake and retention studies of silica nanoparticles utilizing senescent fibroblasts
Perrigue, P. M., Henschke, A., Grześkowiak, B. F., Przysiecka, Ł., Jaskot, K., Mielcarek, A., Coy, E. L., & Moya, S. E. (2023) · Scientific Reports · doi:10.1038/s41598-022-26979-1 · Cited by 16
Falah, G., Giller, A., Gutman, D., & Atzmon, G. (2020) · Gerontology · doi:10.1159/000505995 · Cited by 14
Sherekar, P., Suke, S. G., Dhok, A., Malegaonkar, S. K., & Dhale, S. A. (2025) · Toxicology Reports · doi:10.1016/j.toxrep.2025.101941 · Cited by 12
“It reduces collagen deposition by restoring pulmonary function in PF and improves tumour xenograft regression during chemotherapy by minimizing the toxic side effects of cytotoxic drugs [94].”
Wang, J., Guo, P., Wu, D., Yi, J., Jiang, Q., Hu, J., & Ouyang, H. (2025) · Advanced Science · doi:10.1002/advs.202414419 · Cited by 16
Targeted delivery strategy: A beneficial partner for emerging senotherapy
Zhang, Q., Li, S., Chen, F., Zeng, R., & Tong, R. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113737 · Cited by 14
Xu, J., Cui, Y., Liu, M., An, Z., Li, K., Gu, X., Li, P., & Fan, Y. (2023) · European Polymer Journal · doi:10.1016/j.eurpolymj.2023.112040 · Cited by 11
Mechanisms of Senescence in Cancer: Positive and Negative Aspects of Cancer Cells Senescence
Zaczek, A., Kalenik, S., & Rodacka, A. (2023) · Cellular Physiology and Biochemistry · doi:10.33594/000000671 · Cited by 12
Morellá‐Aucejo, Á., Medaglia, S., Ruiz‐Rico, M., Martínez‐Máñez, R., Marcos, M. D., & Bernardos, A. (2024) · Biomaterials Advances · doi:10.1016/j.bioadv.2024.213840 · Cited by 12
Self-citationAutophagy and senescence: Insights from normal and cancer stem cells
Talukdar, S., Das, S. K., Emdad, L., & Fisher, P. B. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.01.005 · Cited by 13
de Celis, M. F. R., & Bonner‐Weir, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1217729 · Cited by 13
“One approach is to target senescent cells using a sophisticated method of galacto-oligosaccharide-coated nanoparticles, based in the increased lysosomal mass and bgalactosidase activity of senescent cells (88).”
Targeted Therapeutics Delivery by Exploiting Biophysical Properties of Senescent Cells
Low, J., Chan, B., & Tay, A. K. P. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202107990 · Cited by 11
Paternot, S., Raspé, E., Meiller, C., Tarabichi, M., Assié, J., Libert, F., Remmelink, M., Bisteau, X., Pauwels, P., Blum, Y., et al. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13351 · Cited by 10
“Senescent cells harbour vulnerabilities allowing their specific killing by various ‘senolytics’ [24,119], including BCL-2 and BCL-xL inhibitors (venetoclax, navitoclax, A1331852, . . . ) that were observed to augment the tumour response to CDK4/6i [120,121].”
BackgroundLewis, C. J., & de Grey, A. D. (2024) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2024.2330425 · Cited by 10
“Other researchers have continued pursuing this compound however, and have developed prodrug strategies in order to minimize off-target toxicity through PROTAC engineering [64] or galactose encapsulation [65] or conjugation [66].”
Lozano‐Torres, B., Blandez, J. F., García‐Fernández, A., Sancenón, F., & Martínez‐Máñez, R. (2022) · FEBS Journal · doi:10.1111/febs.16477 · Cited by 9
Self-citationCurrent strategies for senescence treatment: Focused on theranostic performance of nanomaterials
Cong, Y., Li, X., & Hong, H. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113710 · Cited by 10
Liu, W., Fan, B., Fang, T., Li, H., Zhang, J., Liu, B., & Liu, Z. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.08.010 · Cited by 10
“Moreover, the exploitation of delivery systems such as nano-particles further improves the therapeutic and diagnostic applications of senolytic drugs 41 .”
Cellular Senescence and Senolytic Agents: Recent Updates on Their Role and Applications
Chandrakar, L., Ambatwar, R., & Khatik, G. L. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266273698231107110956 · Cited by 11
Cellular Plasticity during Metastasis: New Insights Provided by Intravital Microscopy
Margarido, A. S., Bornes, L., Vennin, C., & van Rheenen, J. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a037267 · Cited by 9
Network of extracellular vesicles surrounding senescent cells
Okawa, H., Tanaka, Y., & Takahashi, A. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.109953 · Cited by 8
Zară-Dănceanu, C.-M., García-Fernández, J., Herea, D.-D., Ghercă, D., Carrera, I. D. F., Labusca, L. S., & de la Fuente, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031292 · Cited by 8
“A major challenge is ensuring that senotherapeutic agents reach target tissues in sufficient concentrations; improving bioavailability and developing targeted delivery methods are critical [12,21].”
Aptamers as Diagnostic and Therapeutic Agents for Aging and Age-Related Diseases
Park, T.-I., Yang, A. H., Kanth, B. K., & Pack, S. P. (2025) · Biosensors · doi:10.3390/bios15040232 · Cited by 9
Promise and Perspective of Nanomaterials in Antisenescence Tissue Engineering Applications
Lu, Z., Singh, G., Lesani, P., & Zreiqat, H. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c01298 · Cited by 8
Recent Advancement in Elimination Strategies and Potential Rejuvenation Targets of Senescence
Kureel, S. K., Blair, B., & Sheetz, M. P. (2023) · Advanced Biology · doi:10.1002/adbi.202300461 · Cited by 10
Futuristic Senolytic Drug Incorporated Nanomedicine Therapy to Treat Osteoarthritis
Jha, L. A., Kumar, B., Jha, S. K., & Paudel, K. R. (2024) · Nanomedicine · doi:10.2217/nnm-2023-0348 · Cited by 9
Identification of a Proteomic Signature of Senescence in Primary Human Mammary Epithelial Cells
Delfarah, A., Hartel, N. G., Zheng, D., Yang, J., & Graham, N. A. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00659 · Cited by 8
Senolysis Enabled by Senescent Cell‐Sensitive Bioorthogonal Tetrazine Ligation
Chang, M., Dong, Y., Xu, H., Cruickshank‐Taylor, A. B., Kozora, J. S., Behpour, B., & Wang, W. (2024) · Angewandte Chemie · doi:10.1002/ange.202315425 · Cited by 9
Implications of cellular senescence in paediatric pituitary tumours
González-Meljem, J. M., & Martínez-Barberá, J. P. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104905 · Cited by 9
“49 .”
Targeted Senolytic Strategies Based on the Senescent Surfaceome
Ekpenyong‐Akiba, A. E., Poblocka, M., & Macip, S. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_6 · Cited by 8
Chaib, S., Lopez-Dominguez, J. A., Lalinde-Gutiérrez, M., Prats, N., Marín, I., Meyer, K. R., Muñoz, M. I., Aguilera, M., Mateo, L., Attolini, C. S., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.04.501681 · Cited by 7
Self-citationRademacher, D. J., Exline, J. E., & Foecking, E. M. (2025) · Biomedicines · doi:10.3390/biomedicines13061400 · Cited by 9
“After cellular uptake, fusion with lysosomes, and hydrolysis of the galacto-oligosaccharide coat by SA-β -gal, these NPs released their cytotoxic cargo to selectively kill senescent cells while sparing normal, healthy cells [347].”
Targeting Cellular Senescence with Liposome-Encapsulated Fisetin: Evidence of Senomorphic Effect
Henschke, A., Grześkowiak, B. F., Ivashchenko, O., Sánchez-Cerviño, M. C., Coy, E. L., & Moya, S. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157489 · Cited by 11
Recent Advances in Senotherapeutics Delivery
Choi, J. Y., Yee, S. F., Tchangalova, T., Yang, G., & Fisher, J. P. (2022) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2021.0212 · Cited by 6
“75 The GalNP was used to encapsulate doxorubicin, navitoclax, and rhodamine B and assessed the drug release efficiency and toxicity against SnCs induced by chemotherapy for tumors in vivo .”
Chemo-Senolytic Therapeutic Potential against Angiosarcoma
Wang, X., Chung, C., Yoshioka, A., Hashimoto, S., Jimbo, H., Tanizawa, H., Ohta, S., Fukumoto, T., & Noma, K.-I. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.03.026 · Cited by 7
Chen, L., Lin, A., Luo, P., & Miao, K. (2025) · Nano Research · doi:10.26599/nr.2025.94907609 · Cited by 6
Escriche‐Navarro, B., Garrido, E., Escudero, A. C., Montoya-Méndez, I., Sancenón, F., García‐Fernández, A., & Martínez‐Máñez, R. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123461 · Cited by 7
Self-citationPacifico, F., Crescenzi, E., & Leonardi, A. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1669-7_12 · Cited by 6
The Role of Metallodrugs in Cellular Senescence
Redrado, M., & Fernández‐Moreira, V. (2023) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.202200593 · Cited by 6
Dotou, M., L’honoré, A., Moumné, R., & Amri, C. E. (2024) · Journal of Natural Products · doi:10.1021/acs.jnatprod.3c01195 · Cited by 9
Kaufman, F., David, M., Zaiden, M., Shabat, D., & Amiram, M. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb01334h · Cited by 5
Senotherapeutics in Malignant Brain Cancer Therapy
Kaina, B., & Christmann, M. (2025) · Current Oncology Reports · doi:10.1007/s11912-025-01733-8 · Cited by 5
“Although they provoke cell death through apoptosis, induction of harnessed to deliver cytotoxic agents or senolytic drugs coated with galacto-oligosaccharide nanoparticles into lysosomes of senescent cells [91–93].”
Zhao, Q., Yu, Y., Pu, C., Zheng, S., Chen, L., Zeng, F., Liu, L., & Li, D. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1727142 · Cited by 9
“This strategy enhances the ef fi cacy of senolytics while minimizing systemic toxicity, offering a promising approach to eliminate the persistent, immune-suppressive TIS cell population without harming healthy tissue (163).”
Cox, L. S. (2022) · The Journal of the Economics of Ageing · doi:10.1016/j.jeoa.2022.100423 · Cited by 8
Functional screening to identify senescence regulators in cancer
Lujambio, A., & Banito, A. (2019) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2019.02.001 · Cited by 6
The potential for senotherapy as a novel approach to extend life quality in veterinary medicine
Williams, Z. J., Chow, L., Dow, S., & Pezzanite, L. M. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1369153 · Cited by 6
Brandariz, J., de Llobet, L., Esquefa, V., Aguilar, D., Salca, A., Arce-Gallego, S., Cresta Morgado, P., Sole, A., Agundez, L., Mir, G., et al. (2025) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-24-0903 · Cited by 5
Self-citationHautalterung – zelluläre Seneszenz: Wohin geht die Reise?
Scharffetter‐Kochanek, K., Wang, Y., Makrantonaki, E., Crișan, D., Wlaschek, M., Geiger, H., & Maity, P. (2023) · Die Dermatologie · doi:10.1007/s00105-023-05201-x · Cited by 5
Sénothérapies: Avancées et nouvelles perspectives cliniques
Véret, D., & Brondello, J. (2020) · médecine/sciences · doi:10.1051/medsci/2020220 · Cited by 6
Drug Delivery Strategies for Age-Related Diseases
Yoshihara, K., & Horiguchi, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168693 · Cited by 5
Natural Product-Derived Senotherapeutics: Extraction and Biological Evaluation Techniques
Pratsinis, H., Mavrogonatou, E., Zervou, S., Triantis, T. M., Hiskia, A. E., & Kletsas, D. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4426-3_19 · Cited by 4
Novel Probes and Carriers to Target Senescent Cells
Lozano‐Torres, B., Blandez, J. F., Sancenón, F., & Martínez‐Máñez, R. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_9 · Cited by 4
Self-citationLin, L., Schneiderman, Z., Venkatraman, A., & Kokkoli, E. (2023) · Nanoscale · doi:10.1039/d3nr00196b · Cited by 4
Fernández-Gómez, P., Aranda, C. P. D. L. L., Tosat‐Bitrián, C., de Barrio, J. A. B., Thompson, S. A., Sot, B., Salas, G., Somoza, Á., Espinosa, A., Castellanos, M., et al. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1191327 · Cited by 5
“In addition, targeting key pathological cells present in several diseases such as senescent cells through their high β-galactosidase activity was achieved through galacto-oligosaccharides encapsulated drugs, yielding a versatile strategy potentially effective for multiple pathologies (Munoz-Espin et al., 2018).”
BackgroundMethodInfluentialNew frontier for epilepsy treatment through targeting cellular senescence
Bello, S. T., Rafe, M. R., & Huang, F. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111506 · Cited by 3
Matsuda, M., Ishizu, E., Fujiwara, Y., Shimora, H., Kaibori, Y., Yamagishi, N., Kaminuma, O., & Nabe, T. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103726 · Cited by 3
Meng, B., Qu, Y., Yang, B., Fu, C., He, Y., Li, J., Wan, R., Li, X., Xue, Z., Cao, Z., et al. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01584-5 · Cited by 6
Pan, J., Zhang, S., Xu, Y., Li, Z., Luo, M., Peng, Z., Jin, A., Hou, B., Qin, X., Cui, X., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102709 · Cited by 4
Tan, Q., ZHAO, Y., Zhang, Y., Chen, H., Xu, Z., Pan, Z., El‐Khouly, M. E., & Yuan, Y. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c09336 · Cited by 7
Cellular senescence and nanoparticle-based therapies: Current developments and perspectives
Henschke, A., Mielcarek, A., Grześkowiak, B. F., Perrigue, P. M., Jaskot, K., Coy, E. L., & Moya, S. E. (2024) · Nanotechnology Reviews · doi:10.1515/ntrev-2023-0211 · Cited by 6
“In another work, Muñoz-Espín and colleagues took advantage of the previous fi ndings to encapsulate the therapeutic agent into β (1,4)-galacto-oligosaccharide-coated MSNs (GalNP) and to ensure the release of the cargo within the senescent cells (Figure 2) [155].”
BackgroundSenescent cells: a therapeutic target in correction of aging
Kirichenko, T. V., Markina, Y. V., Markin, A. M., Eremin, I. I., & Deev, R. V. (2024) · Восстановительные биотехнологии, профилактическая, цифровая и предиктивная медицина. · doi:10.17116/rbpdpm2024103153 · Cited by 5
Consequences of senotherapies for tissue repair and reprogramming
van Vliet, T., Kohli, J. S., & Demaria, M. (2019) · Translational Medicine of Aging · doi:10.1016/j.tma.2019.01.003 · Cited by 4
Wyles, S. P., Vyas, K. S., Wasserburg, J. R., Ansaf, R. B., & Kirkland, J. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15500-0.00009-8 · Cited by 4
Lozano‐Torres, B., Blandez, J. F., Galiana, I., García‐Fernández, A., Alfonso, M., Marcos, M. D., Orzáez, M., Sancenón, F., & Martínez‐Máñez, R. (2020) · Angewandte Chemie · doi:10.1002/ange.202004142 · Cited by 3
Self-citationPicallos-Rabina, P., Silva‐Álvarez, S. D., Antelo-Iglesias, L., Triana-Martínez, F., & Collado, M. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_5 · Cited by 3
The Role of Senolytics in Osteoporosis
Chen, E., Zhang, J., Chen, H., & Li, W. (2025) · Biomolecules · doi:10.3390/biom15081176 · Cited by 7
“…of second-generation senolytic strategies, such as lysosomal and senescence-associated β -galactosidase-activated prodrugs and nanoparticles [73,74], apoptosis induction via sodium–potassium pump (Na+/K+-ATPase) modulation [75], SASP inhibition [76], and immune-mediated clearance approaches,…”
Engineering Aging: Approaches to Model and Deconstruct Biological Complexity
Joukhdar, H., Lee, S. S., Cox, T. R., Choi, Y. S., Wise, S. G., Young, J. L., Yeo, G. C., & Lim, K. S. (2025) · Advanced Materials · doi:10.1002/adma.202512523 · Cited by 2
Toward precision longevity: aging interventions in the single-cell atlas era
Chen, J. B., Wang, M. C., Gong, S., & Li, H. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1674112 · Cited by 2
Vardon, A., Haston, S., Hamdi, H., Cooksley, G., Guiho, R., Carvalho, D. M., Carter, R., Boult, J. K. R., Gharai, D., Cloete, I., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-32676-6 · Cited by 4
Self-citationSingh, D., & Bhattacharya, S. (2026) · Therapeutic Delivery · doi:10.1080/20415990.2026.2668850 · Cited by 3
Hartono, M., Ge, J., Denholm, M., Ellis, M. G., Henríquez, J. A., Baker, A. G., Rintoul, R. C., Euser, T. G., Fruk, L., & Muñoz‐Espín, D. (2026) · Nature Aging · doi:10.1038/s43587-026-01116-z · Cited by 2
“Multiple senolytics have been validated in pre-clinical models and can synergize with existing senescence-inducing cancer chemotherapies; early-phase clinical trials are also reporting promising results 23,25,26 .”
Self-citationWang, J., Wang, J., Gao, S., Qian, K., Ding, Q., & Cheng, Z. (2026) · iRadiology · doi:10.1002/ird3.70084 · Cited by 2
Nanoparticles as an efficient strategy to eliminate senescent brain endothelial cells
Tomé, I., Rosa, S., Sanfeliu-Redondo, D., Caramelo, F. J., Khan, A. S., Aristu-Zabalza, P., Vizioli, M. G., Pitrez, P. R., Malva, J. O., Sancho, J.-G., et al. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115174 · Cited by 2
An Indocyanine Green‐Based Nanoprobe for In Vivo Detection of Cellular Senescence
Baker, A. G., Hartono, M., Ou, H., Bistrović, A., Brown, E. L., Joseph, J., Golinska, M. A., González‐Gualda, E., Macías, D., Ge, J., et al. (2024) · Angewandte Chemie · doi:10.1002/ange.202404885 · Cited by 2
Self-citationBi, J., Zeng, J., Liu, X., Mo, C., Yao, M., Zhang, J., Yuan, P., Jia, B., & Xu, S. (2024) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2024.102209 · Cited by 2
Senotherapy: Implications for Transplantation
Jaros, M., & Melk, A. (2025) · Transplantation · doi:10.1097/tp.0000000000005291 · Cited by 3
Senolytics Target Senescent Cells and Improve Aging and Age-Related Diseases
Buffard, T., & Ferbeyre, G. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_4 · Cited by 4
Martínez‐Zamudio, R. I., & Herbig, U. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_38-1 · Cited by 2
pH Stimuli Responsive Dextran Gated Mesoporous Silica as a Viable Delivery VehiclePreprint
Waidi, Y. O. (2024) · ChemRxiv · doi:10.26434/chemrxiv-2024-7z779 · Cited by 2
New Horizons in Myotonic Dystrophy Type 1: Cellular Senescence as a Therapeutic Target
Légaré, C., Berglund, J. A., Duchesne, É., & Dumont, N. A. (2024) · BioEssays · doi:10.1002/bies.202400216 · Cited by 2
“For instance, Muñoz-Espín et al. found a way to deliver drugs directly to senescent cells by encapsulating them in galacto-oligosaccharide [62].”
Balancing senescence and apoptosis: therapeutic insights into aging and cancer
Jan, N., Sofi, S., Mir, A. A., Masoodi, G., & Mir, M. A. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05355-3 · Cited by 4
Mirroring tissue senescence in human biofluids
Gorgoulis, V. G., & Chrousos, G. P. (2026) · Nature Aging · doi:10.1038/s43587-026-01112-3 · Cited by 1
Tilting the balance of life and death: navigating DNA replication stress in cancer therapy
Lo, N., & Kim, H. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01745-9 · Cited by 3
“One such strategy is the development of the prodrug Nav-Gal, a navitoclax – galactose conjugate speci fi cally cleaved by elevated β -galactosidase activity in senescent cells 152,153 .”
Yang, Z., Ou, X., Tang, Z., Nong, Z., Lu, X., Zhang, X., Suo, M., Meng, Z., Deng, S., Shangguan, P., et al. (2026) · ACS Nano · doi:10.1021/acsnano.6c03475 · Cited by 1
Landucci, E., Castellacci, R., Puente-Sanz, A., Mazzantini, C., Pellegrini-Giampietro, D. E., Bilia, A. R., & Bergonzi, M. C. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108648 · Cited by 1
The Physical Senotype in cellular senescence: Mechanical and physical strategies for senotherapy
Wang, B., Qi, X., Huard, J., & Mu, X. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103283 · Cited by 1
The vicious cycle of SASP and inflammaging promotes aging and age-related diseases
Liu, Q., Zheng, Y., & Sun, C. (2026) · Communications Biology · doi:10.1038/s42003-026-10826-4 · Cited by 1
“Efforts are underway to improve targeted drug delivery based on senescent cell-speci fi c features like elevated β -galactosidase activity, dependence on anti-apoptotic proteins, or unique surface markers 84,155 .”
Potential Applications of Aptamers for Targeting Senescent Cells
Leonardi, A., Pacifico, F., & Crescenzi, E. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_10 · Cited by 1
González‐Gualda, E., Ou, H., Macías, D., & Muñoz‐Espín, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00016-x · Cited by 2
Self-citationA novel platform for precise senolysis
Conti, A., & Micco, R. D. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112056 · Cited by 2
Lérida‐Viso, A. (2023) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/194709 · Cited by 1
Redgrave, R. E., Booth, L. K., & Richardson, G. D. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf220 · Cited by 1
Ageing here and now: current research and transformative therapies
Cox, L. S., & Goljanek‐Whysall, K. (2019) · Biogerontology · doi:10.1007/s10522-019-09814-5
Birth and death of cellular senescence
Wang, B. (2020) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.131223530
Novel probes, carriers and prodrugs to target senescent cells in vivo
Lozano‐Torres, B. (2021) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/172175
Self-citationMartínez‐Zamudio, R. I., & Herbig, U. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_38
Aging principles and interventional perspectives
Sikora, E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90581-7.00002-5
Preclinical evaluation of senescence-based strategies to improve cancer therapy
Estepa‐Fernández, A. (2022) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/188845
An Overview of the EORTC-CLTG 2022 Congress
Humphry, N. (2022) · EMJ Oncology · doi:10.33590/emjoncol/10045588
Duro-Sánchez, S., Nadal-Serrano, M., Lalinde-Gutiérrez, M., Arenas, E. J., Bernadó Morales, C., Morancho, B., Escorihuela, M., Pérez-Ramos, S., Escrivá-de-Romaní, S., Gandullo-Sánchez, L., et al. (2023) · doi:10.1158/0008-5472.c.6514164
Metadata
- Authors
- Muñoz‐Espín, D., Rovira, M., Galiana, I., Giménez, C., Lozano‐Torres, B., Paez‐Ribes, M., Llanos, S., Chaib, S., Muñoz‐Martín, M., Ucero, A. C., Garaulet, G., Mulero, F., Dann, S. G., VanArsdale, T., Shields, D. J., Bernardos, A., Murguía, J. R., Martínez‐Máñez, R., & Serrano, M.
- Affiliations
- University of Cambridge (GB)
- Spanish National Cancer Research Centre (ES)
- Universitat de València (ES)
- Pfizer (United States) (US)
- Institució Catalana de Recerca i Estudis Avançats (ES)
- Corresponding author
- Muñoz‐Espín, Daniel
- Serrano, Manuel
- ORCID
- Venue
- EMBO Molecular Medicine
- Published
- 2018-07-16
- Volume
- 10
- Issue
- 9
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- PMC
- PMC6127887
- OpenAlex
- W2884253843
- Cited by
- 339
- References
- 64
- Citations by year
- 2026: 33 · 2025: 48 · 2024: 52 · 2023: 45 · 2022: 48 · 2021: 28 · 2020: 52 · 2019: 31 · 2018: 2
- FWCI
- 19.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- EMBO Molecular Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- RiuNet (Universitat Politècnica de València) (submittedVersion, cc-by-nc-nd)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- Secretaría de Estado de Investigación, Desarrollo e Innovación (MAT2015‐64139‐C4‐1‐R)
- H2020 European Research Council
- Instituto de Salud Carlos III (DTS16/00205)
- European Regional Development Fund
- European Social Fund
- Institut Ruđer Bošković
- Fundación Botín
- Banco Santander
- “la Caixa” Foundation
- Cancer Research UK (C9685‐A25177, RG86786)
- Generalitat Valenciana (PROMETEOII/2014/047)
- Pfizer
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- senolytics, senescent cells, drug delivery systems, galactooligosaccharides, lysosomal beta-galactosidase, chemotherapy-induced senescence, palbociclib, age-related diseases
- MeSH terms
- Animals, beta-Galactosidase, Cell Survival, Cytotoxins, Disease Models, Animal, Drug Compounding, Fluorescent Dyes, Galactose, Lysosomes, Neoplasm Transplantation, Neoplasms, Oligosaccharides, Piperazines, Pyridines, Staining and Labeling, Drug Delivery Systems, Cellular Senescence, Mice, Heterografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.